137 related articles for article (PubMed ID: 32534880)
1. Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy.
Chávez-Castillo CE; Medellín-Garibay SE; Milán-Segovia RDC; Rodríguez-Leyva I; Romano-Moreno S
J Pharm Sci; 2020 Sep; 109(9):2902-2908. PubMed ID: 32534880
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
3. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.
Grasela TH; Fiedler-Kelly J; Cox E; Womble GP; Risner ME; Chen C
J Clin Pharmacol; 1999 Apr; 39(4):373-84. PubMed ID: 10197296
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I
Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250
[TBL] [Abstract][Full Text] [Related]
6. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B
Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of lamotrigine in patients with epilepsy.
Milovanovic JR; Jankovic SM
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):752-60. PubMed ID: 19954714
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients with Epilepsy.
Yang H; Zhang D; Wei S; Zhao Z; Mei S
Ther Drug Monit; 2024 Apr; ():. PubMed ID: 38666475
[TBL] [Abstract][Full Text] [Related]
9. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
Zhang S; Wang L; Lu W
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
[TBL] [Abstract][Full Text] [Related]
10. Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic Models.
Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
J Clin Pharmacol; 2021 May; 61(5):677-687. PubMed ID: 33244764
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics Modeling of Lamotrigine in Jordanian Epileptic Patients Using Dried Blood Spot Sampling.
Dodin YI; Suyagh MF; Saleh MI; Nuseir ZT; Aburuz SM; Al-Qudah AA; Masri AT; Younes AM; Al-Ghazawi MA
Drug Res (Stuttg); 2021 Oct; 71(8):429-437. PubMed ID: 34255318
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data.
Hussein Z; Posner J
Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
Eriksson AS; Hoppu K; Nergårdh A; Boreus L
Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
[TBL] [Abstract][Full Text] [Related]
15. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Riva R; Albani F; Avoni P; Baruzzi A
Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
[TBL] [Abstract][Full Text] [Related]
18. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.
Brzaković BB; Vezmar Kovačević SD; Vučićević KM; Miljković BR; Martinović ZJ; Pokrajac MV; Prostran MŠ
J Clin Pharm Ther; 2012 Dec; 37(6):693-7. PubMed ID: 22583007
[TBL] [Abstract][Full Text] [Related]
19. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V
Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142
[TBL] [Abstract][Full Text] [Related]
20. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
